Pure Global

Smart Flex Stent System for the Treatment Long Femoropopliteal Artery Lesions - Trial NCT05894863

Access comprehensive clinical trial information for NCT05894863 through Pure Global AI's free database. This phase not specified trial is sponsored by RenJi Hospital and is currently Recruiting. The study focuses on Peripheral Arterial Disease. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT05894863
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov • NCT05894863
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Smart Flex Stent System for the Treatment Long Femoropopliteal Artery Lesions
Smart Flex Stent System for the Treatment Long Femoropopliteal Artery Lesions: the SAFARI Study

Study Focus

Smart flex stent

Interventional

device

Sponsor & Location

RenJi Hospital

Shanghai, China

Timeline & Enrollment

N/A

May 31, 2023

Jan 02, 2027

120 participants

Primary Outcome

Primary patency,Freedom of major adverse events (MAEs)

Summary

This study aims to evaluate the effectiveness and safety of the Smart flex stent system in
 treating long femoropopliteal native lesions.

ICD-10 Classifications

Peripheral vascular disease, unspecified
Other peripheral vascular diseases
Other specified peripheral vascular diseases
Peripheral angiopathy in diseases classified elsewhere
Other congenital malformations of peripheral vascular system

Data Source

ClinicalTrials.gov

NCT05894863

Device Trial